OCA
NUVB.WS

Octagon Capital Advisors’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Octagon Capital Advisors’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-104,112
Closed -$385K – 34
2025
Q3 		$385K Sell
104,112
-50,000
-32% -$10.5K 0.06% 27
2025
Q2 		$301K Sell
154,112
-27,176,688
-99% -$6.28M 0.07% 30
2025
Q1 		$48.1M Buy
27,330,800
+27,018,464
+8,650% +$6.91M 9.31% 1
2024
Q4 		$831K Hold
312,336
– – 0.14% 33
2024
Q3 		$715K Buy
+312,336
New +$54.7K 0.11% 38

Other funds holding NUVB.WS

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GCM
Greenland Capital Management New York $812M AUM 45.54% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Octagon Capital Advisors's NUVB.WS Position: Q4 2025 in Review

Octagon Capital Advisors sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q4 2025, closing a stake of 104,112 shares — an estimated $385K sold.

Octagon Capital Advisors first reported a position in NUVB.WS in Q3 2024 and held it in 5 quarters. The position peaked at $48.1M in Q1 2025. 21 funds tracked by Wall St. Rank hold NUVB.WS as of Q4 2025.

  • Octagon Capital Advisors reported no remaining Nuvation Bio Inc Warrants position as of Q4 2025 after selling out during the quarter.
  • Octagon Capital Advisors sold 104,112 Nuvation Bio Inc Warrants shares in Q4 2025, an estimated $385K.
  • Octagon Capital Advisors first reported a position in Nuvation Bio Inc Warrants in Q3 2024 and held it in 5 quarters.
  • Octagon Capital Advisors's Nuvation Bio Inc Warrants position peaked at $48.1M in Q1 2025.
  • 21 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q4 2025.

Based on Octagon Capital Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.